Low-dose CT scans offer early detection and improved survival rates. And CMS will pay for them.
2016 will feature more advancements in screening and treatment.
An emerging area of FDA regulation
Proponents hail its potential to spur cancer cures, but critics aren't so sure about the 21st Century Cures Act